- 
                        Pfizer Lawsuits Allege Novo Nordisk’s Bid to Buy Obesity Biotech Metsera is Anticompetitive, Illegal
                        03 Nov 2025 22:04 GMT
                        
 … 9 billion acquisition of obesity drug developer Metsera, but whether  … broad pipeline of additional obesity drugs in various stages of  … its merger deal with the biotech due to the significant  … offer represents a dominant obesity drug company’s attempt to  …
                       
                      - 
                        MLTX SHAREHOLDER ALERT: MoonLake Immunotherapeutics (MLTX) Faces Securities Class Action After Company Reported Disastrous Phase 3 Trial Data For Sole Drug Candidate -- Hagens Berman
                        03 Nov 2025 18:12 GMT
                        
 …  for SLK. The clinical stage biotechnology company is focused on skin …  that “we really have a drug here that can become the …
                       
                      - 
                        BIO CEO John Crowley tells Senate how to support biotech
                        03 Nov 2025 16:47 GMT
                        
                          Maintaining America’s biotechnology leadership requires Food and Drug Administration (FDA) modernization as …  FDA and enhancing the domestic drug supply chain.
                          He also urged …  of the world’s biotech-related patents for drugs. Backed by the …
                        
                       
                      - 
                        Legend Biotech Announces 10 Presentations at the 67th American Society of Hematology (ASH) Annual Meeting
                        03 Nov 2025 16:05 GMT
                        
 … ) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global  … Chief Executive Officer of Legend Biotech. “With nine abstracts highlighting …  U.S. Food and Drug Administration (FDA) under the  … -cel also received Orphan Drug Designation from the U.S …
                       
                      - 
                        SA53 MDM2 Inhibitor: Lamassu Biotech Reports Significant Progress, Favorable Safety Profile in Phase 1/2a Clinical Trial
                        03 Nov 2025 15:00 GMT
                        
                           … com/ -- Lamassu Biotech, a clinical-stage pharmaceutical  …  the efficacy of the drug.
                          
                          The trial is overseen … Chief Scientific Officer for Lamassu Biotech. "The strong  …  HERE. 
                           
                          
                           
                          ABOUT LAMASSU BIOTECH
                          Lamassu Biotech is a private pioneering …
                        
                       
                      - 
                        Mumtalakat, SandboxAQ partnership aims to make Bahrain biotech hub
                        03 Nov 2025 14:39 GMT
                        
                           … for the Kingdom through new biotech assets.   
                          The collaboration  … aimed at developing valuable new drugs. 
                          Shaikh Abdulla bin Khalifa … catalyze a new IP-generating biotech economy. Our collaboration will …  power of AI to accelerate drug discovery      and will  …
                        
                       
                      - 
                        Boston biotech Manifold partners with Roche to tackle neurological diseases
                        03 Nov 2025 13:30 GMT
                        
 … giant Roche to develop a drug for neurological disease using  … for founding more than 20 biotech companies, including gene-editing  … research milestones and — if a drug is created — tiered royalties.  … a new approach to deliver drugs to the brain, overcoming  …
                       
                      - 
                        ‘Biotech Barbie’ says the time has come to consider CRISPR babies. Do scientists agree?
                        03 Nov 2025 12:15 GMT
                        
 …  university to found her first biotechnology company at the age of … . Tie, who has called herself Biotech Barbie, sometimes refers to her … , and the US Food and Drug Administration cannot approve clinical use …
                       
                      - 
                        How T3 scaled faster in Basel’s biotech labs
                        03 Nov 2025 12:14 GMT
                        
T3 started with a precise idea and a small team. Early experiments ran within the Basel Area ecosystem. When it was time to scale, they chose the newly built Main Campus. The team moved into a private wet lab, plugged into a curated peer community and  …
                       
                      - 
                        Krystal Biotech Announces Third Quarter 2025 Financial and Operating Results
                        03 Nov 2025 12:00 GMT
                        
 … intended to provide efficiencies in drug development, manufacturing, and review …  processes for drug product applications that incorporate designated … . Prescribing Information. About Krystal Biotech, Inc. Krystal Biotech, Inc. (NASDAQ: KRYS) …